Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $699M bought by 128 insiders at 87 companies
- $1.3B sold by 80 insiders outside a trading plan
- $1B sold by 336 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$247M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.4M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$66.3M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$62M
-
GMEGameStop CorporationRyan CohenCEO$17.1M
-
AVRAnteris Technologies Global Corp.L1 Capital Pty Ltd10% owner$9.7M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$6.2M
-
PAMPampa Energia S.A.Damian Miguel MindlinVicepresident$5.6M
-
GPUSHyperscale Data, Inc.Milton C Ault IIIChair · +1 joint filer$5.1M
Biggest sales
Past week · by insider, all their filings added up · planned sales marked
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
CBRSCerebras Systems Inc.Dhiraj MallickCOO$80.8M
-
CRWDCrowdStrike Holdings, Inc.Michael SentonasPresident$64.2M
-
AAPLApple Inc ComTimothy D CookChair$63.8M
-
MPWRMonolithic Power Systems, Inc.Michael HsingCEO$40.3M
-
ACTEnact Holdings, Inc.Genworth Holdings, Inc.10% owner$37.1M
-
WDAYWorkday, Inc.David A Duffield10% owner$37.1M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.5M 12,900 shares at $116.58 <0.1% of stakeTraded Sep 17 Filed Sep 21
-
Gang Ye COOSESea LimitedPlanned sale$4.1M 40,000 shares at $101.88 6.3% of stakeTraded Sep 17–18 Filed Sep 21
-
Tianyu Hou CFOSESea LimitedPlanned sale$1.5M 15,000 shares at $101.62 75% of stakeTraded Sep 17 Filed Sep 21
-
Jingye Chen CPO, ShopeeSESea LimitedPlanned sale$6.1M 60,000 shares at $101.52 50% of stakeTraded Sep 17–18 Filed Sep 21
-
Eric P Lefkofsky CEOTEMTempus AI, Inc.Planned sale$16.1M 200,000 shares at $80.57 20% of stakeTraded Sep 17 Filed Sep 18
-
Vikram Verghese CFOHTFLHeartflow, Inc.Planned sale$1.2M 24,345 shares at $50.55 14% of stakeTraded Sep 17–18 Filed Sep 18
-
Marc E Berg EVP & Secretary/TreasurerIHTInnSuites Hospitality TrustPlanned sale$361M 16,000 shares at $22,593.60 33% of stakeTraded Sep 17 Filed Sep 18
-
Luis Von Ahn CEODUOLDuolingo, Inc.Planned sale$4.3M 28,292 shares at $150.22 100% of stakeTraded Sep 16 Filed Sep 18
-
Francis Lo Chief People OfficerADPTAdaptive Biotechnologies CorporationPlanned sale$3.2M 115,406 shares at $28.06 34% of stakeTraded Sep 16 Filed Sep 18
-
Shantanu Narayen CEOADBEAdobe Inc.Sale$31.3M 125,000 shares at $250.76 34% of stakeTraded Sep 16–17 Filed Sep 18
-
Laura Alber CEOWSMWilliams-Sonoma, Inc.Planned sale$7.7M 35,000 shares at $221.20 3.9% of stakeTraded Sep 16 Filed Sep 18
-
Joseph Baratta DirectorBXBlackstone Inc.Sale$12.4M 100,000 shares at $123.80 12% of stakeTraded Sep 18 Filed Sep 18
-
Anthony Mathew Eisen DirectorXYZBlock, Inc.Planned sale$1.4M 18,000 shares at $77.63 1.3% of stakeTraded Sep 16–18 Filed Sep 18
-
Michael Schmertzler DirectorPTCTPTC Therapeutics, Inc.Planned sale$1.3M 20,000 shares at $67.49 1.5% of stakeTraded Sep 16–17 Filed Sep 18
-
Colette Kress CFONVDANvidia Corporation ComPlanned sale$7.6M 34,918 shares at $219.05 4.4% of stakeTraded Sep 17 Filed Sep 18
-
Yuen Wupen President, Global Bus. UnitsLITELumentum Holdings Inc.Planned sale$1.4M 1,500 shares at $903.43 1.3% of stakeTraded Sep 16–18 Filed Sep 18
-
Kumar Budur Chief Medical OfficerHRMYHarmony Biosciences Holdings, Inc.Planned sale$1.7M 38,452 shares at $43.05 75% of stakeTraded Sep 16–18 Filed Sep 18
-
Masatoshi Koide Pres. and Rep. Director, ALIJAFLAflac IncorporatedSale$1.6M 13,201 shares at $118.01 15% of stakeTraded Sep 16 Filed Sep 18
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.2M 64,000 shares at $97.49 12% of stakeTraded Sep 17–18 Filed Sep 18
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $496.06 2.8% of stakeTraded Sep 17 Filed Sep 18
-
John R. Furner CEOWMTWalmart Inc.Planned sale$1.4M 13,125 shares at $106.66 2% of stakeTraded Sep 17 Filed Sep 18
-
Paul A Mahon EVP & General CounselUTHRUnited Therapeutics CorporationPlanned sale$4.1M 8,300 shares at $497.54 16% of stakeTraded Sep 17 Filed Sep 18
-
Edward Carr Chief Accounting OfficerDNTHDianthus Therapeutics, Inc.Planned sale$2M 20,000 shares at $101.38 100% of stakeTraded Sep 17 Filed Sep 18
-
Sl Spv-2, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$26.7M 46,994 shares at $567.88 34% of stakeTraded Sep 16 Filed Sep 18
-
Silver Lake Partners IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$32.3M 56,794 shares at $567.89Traded Sep 16 Filed Sep 18
-
George Raymond Zage III DirectorGRNDGrindr Inc.Planned sale$7.8M 500,000 shares at $15.55 6.2% of stakeTraded Sep 16–17 Filed Sep 18
-
Silver Lake Partners V DE (AIV), L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$15.3M 26,985 shares at $567.88 36% of stakeTraded Sep 16 Filed Sep 18
-
Richard M Schulze InsiderBBYBest Buy Co., Inc.Sale$27.8M 300,000 shares at $92.51 100% of stakeTraded Sep 16 Filed Sep 18
-
David Fortunato CEOWLTHWealthfront CorporationPlanned sale$1M 100,000 shares at $10.14Traded Sep 17 Filed Sep 18
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge Financial Inc.Buy$11.2M 320,785 shares at $35.02 +0.3% to stakeTraded Sep 16 Filed Sep 18
-
Mauad Bruno Sousa DirectorAUGOAura Minerals Inc.Sale$6.8M 73,925 shares at $92.40 86% of stakeTraded Sep 17 Filed Sep 18
-
Lingke Wang PresidentLIFEEthos Technologies Inc.Planned sale$4.6M 118,333 shares at $38.96 7.1% of stakeTraded Sep 17 Filed Sep 18
-
Peter George Colis CEOLIFEEthos Technologies Inc.Planned sale$2.7M 70,000 shares at $38.51 4.4% of stakeTraded Sep 16–18 Filed Sep 18
-
Tajinder S Vohra Please See RemarksRVTYRevvity, Inc.Planned sale$1M 7,330 shares at $140.88 53% of stakeTraded Sep 16 Filed Sep 18
-
Robert L Bugbee PresidentSTNGScorpio Tankers Inc.Sale$22.2M 256,799 shares at $86.28 29% of stakeTraded Sep 16–17 Filed Sep 18
-
John R Buran DirectorOCFCOceanFirst Financial Corp.Sale$2.2M 113,630 shares at $19.40 100% of stakeTraded Aug 7 Filed Sep 18
-
Cameron Keyser Mackey COOSTNGScorpio Tankers Inc.Sale$11.1M 125,000 shares at $89.03 15% of stakeTraded Sep 17 Filed Sep 18
-
Christopher John Avella CFOSTNGScorpio Tankers Inc.Sale$4.9M 56,500 shares at $86.57 24% of stakeTraded Sep 16 Filed Sep 18
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.6M 13,800 shares at $117.49 <0.1% of stakeTraded Sep 16 Filed Sep 18
-
Jeffrey D Benjamin DirectorGOLDGold.com, Inc.Sale$1.1M 22,625 shares at $47.70 7% of stakeTraded Sep 16–17 Filed Sep 18
-
David Stinnett DirectorKRMNKarman Holdings Inc.Buy$1M 27,000 shares at $37.32 +0.8% to stakeTraded Sep 16 Filed Sep 18
-
Michael P. Lyons CEOTFCTruist Financial CorporationBuy$1M 21,000 shares at $48.36 New stakeTraded Sep 17 Filed Sep 18
-
Bruno Constantino Alexandre Dos Santos DirectorXPXP Inc.Sale$2.4M 123,257 shares at $19.58 7.6% of stakeTraded Sep 16 Filed Sep 17
-
William E. Rote Chief Research OfficerTVTXTravere Therapeutics, Inc.Planned sale$13.1M 209,048 shares at $62.83 68% of stakeTraded Sep 15–16 Filed Sep 17
-
Jonathan Sheena FounderNTRANatera, Inc.Planned sale$3.2M 9,150 shares at $351.49 4% of stakeTraded Sep 15–16 Filed Sep 17
-
Peter Heerma EVP, Chief Commercial OfficerTVTXTravere Therapeutics, Inc.Planned sale$17.9M 283,189 shares at $63.06 71% of stakeTraded Sep 15–17 Filed Sep 17
-
Jula Inrig EVP, Head of R&D & CMOTVTXTravere Therapeutics, Inc.Planned sale$2.8M 44,674 shares at $62.34 31% of stakeTraded Sep 15 Filed Sep 17
-
Elizabeth E Reed Chief Legal Officer and GCTVTXTravere Therapeutics, Inc.Planned sale$2.3M 37,500 shares at $62.34 26% of stakeTraded Sep 15 Filed Sep 17
-
Eric M Dube CEOTVTXTravere Therapeutics, Inc.Planned sale$25.4M 400,000 shares at $63.48 48% of stakeTraded Sep 15–17 Filed Sep 17
-
Christopher R. Cline CFOTVTXTravere Therapeutics, Inc.Planned sale$3.1M 50,508 shares at $62.34 37% of stakeTraded Sep 15 Filed Sep 17
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.